Juan Frias, Medical Director of the National Research Institute in Los Angeles, discussed tirzepatide, a dual GIP/GLP-1 under investigation for people with obesity resulting in significant weight loss
This prolonged presence is actually beneficial for treatment adherence, as it allows for once-weekly dosing rather than daily injections
The FDA notes that all work best alongside a healthy diet and regular movement
Arch Dis Child 91: 183-187
"These findings raise important questions for future obesity research," Mehta says
14 Another study showed that four months of daily oral glutathione supplementation, combined with lifestyle improvements, produced positive effects on liver health in some individuals with non-alcoholic fatty liver disease (NAFLD)